SXTPW Form 3: COO Kristen Landon Reports No Holdings; Late Filing

Rhea-AI Filing Summary

60 Degrees Pharmaceuticals (SXTP/SXTPW) filing an initial Form 3 showed the reporting person, Kristen Landon, Chief Operating Officer, reports no beneficial ownership of the issuer's securities. The event date triggering the report is 02/12/2024. The filing notes it was submitted late due to an inadvertent administrative error. The form is signed by Ms. Landon on 08/14/2025, and there are no listed non-derivative or derivative holdings on the schedules.

Positive

• Officer identified as Chief Operating Officer, clarifying reporting hierarchy
• Form 3 filed discloses status of beneficial ownership (no holdings)

Negative

• Late filing acknowledged due to an inadvertent administrative error

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Landon Kristen

(Last) (First) (Middle)

C/O 60 DEGREES PHARMACEUTICALS, INC.

1025 CONNECTICUT AVENUE NW SUITE 1000

(Street)

WASHINGTON DC 20036

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/12/2024

3. Issuer Name and Ticker or Trading Symbol
60 DEGREES PHARMACEUTICALS, INC. [ SXTP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned. This Form 3 is being filed late due to an inadvertent administrative error.

No securities are beneficially owned.

	/s/ Kristen Landon	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 3 for 60 Degrees Pharmaceuticals (SXTPW) disclose?

The Form 3 states that Kristen Landon, the Chief Operating Officer, does not beneficially own any securities of the issuer and that the filing was late due to an inadvertent administrative error.

Who is the reporting person on the Form 3 and what is their role?

The reporting person is Kristen Landon, listed as the company's Chief Operating Officer and an officer of the issuer.

What is the event date that required the Form 3 filing?

The event date requiring the statement is 02/12/2024.

When was the Form 3 signed and submitted?

The signature on the form is dated 08/14/2025, and the filing text states it was filed late for administrative reasons.

Does the Form 3 list any derivative or non-derivative securities owned?

No. The schedules indicate no non-derivative or derivative securities are beneficially owned by the reporting person.